Suppr超能文献

SARS-CoV-2 总免疫球蛋白在一系列恢复期血浆和献血者中的持续存在。

Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.

机构信息

Centro de Hemoterapia y Hemodonacion de Castilla y Leon, Valladolid, Castilla y León, Spain.

出版信息

PLoS One. 2022 Feb 24;17(2):e0264124. doi: 10.1371/journal.pone.0264124. eCollection 2022.

Abstract

BACKGROUND

The vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study was to determine how long total anti-SARS-CoV2 antibodies due to past infection persist in peripheral blood and whether sex, age or haematological features can influence their lasting.

MATERIAL AND METHODS

A series of 2421 donations either of SARS-CoV-2 convalescent plasma or whole blood from 1107 repeat donors from January 2020 to March 2021 was analysed. An automated chemiluminescence immunoassay for total antibodies recognizing the nucleocapsid protein of SARS-CoV-2 in human serum and plasma was performed. Sex, age, blood group, blood cell counts and percentages and immunoglobulin concentrations were extracted from electronic recordings. Blood donation is allowed after a minimum of one-month post symptom's relapse. Donors were 69.7% males and their average age was 46. The 250 donors who had later donations after a positive one underwent further analysis. Both qualitative (positivity) and quantitative (rise or decline of optical density regarding consecutive donations) outcomes were evaluated.

RESULTS AND DISCUSSION

In 97.6% of donors with follow-up, anti-SARS-CoV-2 protein N total antibodies remained positive at the end of a follow-up period of 12.4 weeks median time (1-46, SD = 9.65) after the first positive determination. The blood group was not related to antibody waning. Lower lymphocyte counts and higher neutrophils would help predict future waning or decay of antibodies. Most recovered donors maintain their total anti-SARS-CoV-2 N protein antibodies for at least 16 weeks (at least one month must have been awaited from infection resolution to blood donation). The 10 individuals that could be followed up longer than 40 weeks (approximately 44 weeks after symptom's relapse) were all still positive.

摘要

背景

绝大多数有症状和无症状的 COVID-19 病例在感染 COVID-19 后都会产生免疫力。感染和疫苗接种引起的免疫力是否存在持久差异尚不清楚。本研究旨在确定过去感染导致的外周血总抗 SARS-CoV2 抗体能持续多长时间,以及性别、年龄或血液学特征是否会影响其持续时间。

材料和方法

分析了 2020 年 1 月至 2021 年 3 月期间来自 1107 名重复供体的 2421 份 SARS-CoV-2 恢复期血浆或全血捐献者的系列样本。对人血清和血浆中 SARS-CoV-2 核衣壳蛋白总抗体进行了自动化化学发光免疫分析。从电子记录中提取了性别、年龄、血型、血细胞计数和百分比以及免疫球蛋白浓度。在症状缓解后至少一个月才允许献血。供体中 69.7%为男性,平均年龄为 46 岁。在最初检测呈阳性后进行了进一步分析的 250 名有后续检测的供体。对定性(阳性)和定量(连续捐献时光密度的上升或下降)结果进行了评估。

结果和讨论

在有随访的 97.6%的供体中,在最初阳性检测后 12.4 周的中位随访时间(1-46,SD = 9.65)结束时,抗 SARS-CoV-2 蛋白 N 总抗体仍呈阳性。血型与抗体衰减无关。较低的淋巴细胞计数和较高的中性粒细胞计数有助于预测抗体的未来衰减或下降。大多数康复供体至少能维持 16 周的总抗 SARS-CoV-2 N 蛋白抗体(从感染痊愈到献血至少需要等待一个月)。10 名可随访时间超过 40 周(约在症状缓解后 44 周)的个体仍为阳性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/8870513/bb886a887e87/pone.0264124.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验